WPD Pharmaceuticals Inc. (CSE:WBIO)
0.0700
-0.1200 (-63.16%)
Feb 20, 2025, 5:23 PM EST
WPD Pharmaceuticals Statistics
Total Valuation
CSE:WBIO has a market cap or net worth of CAD 324,763. The enterprise value is 706,303.
| Market Cap | 324,763 |
| Enterprise Value | 706,303 |
Important Dates
The next estimated earnings date is Friday, December 12, 2025.
| Earnings Date | Dec 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:WBIO has 4.64 million shares outstanding.
| Current Share Class | 4.64M |
| Shares Outstanding | 4.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.65% |
| Owned by Insiders (%) | 22.38% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -105.32 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -71.58% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 115.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -419 |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.06 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 39.20 |
| Average Volume (20 Days) | 3,503 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -290,036 |
| Pretax Income | -6,706 |
| Net Income | -6,706 |
| EBITDA | -285,095 |
| EBIT | -290,036 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 9,339 in cash and 390,880 in debt, giving a net cash position of -381,541 or -0.08 per share.
| Cash & Cash Equivalents | 9,339 |
| Total Debt | 390,880 |
| Net Cash | -381,541 |
| Net Cash Per Share | -0.08 |
| Equity (Book Value) | -622,289 |
| Book Value Per Share | -0.13 |
| Working Capital | -487,443 |
Cash Flow
| Operating Cash Flow | -171,987 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:WBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.57% |
| Shareholder Yield | -0.57% |
| Earnings Yield | -2.06% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 30, 2024. It was a reverse split with a ratio of 0.04.
| Last Split Date | Dec 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |